2H-1-Benzopyran-7-ol, 8-[5-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]-2,2-dimethyl- manufacturers
|
| | 2H-1-Benzopyran-7-ol, 8-[5-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]-2,2-dimethyl- Basic information |
| | 2H-1-Benzopyran-7-ol, 8-[5-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]-2,2-dimethyl- Chemical Properties |
| Boiling point | 526.6±60.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | pka | 9.02±0.40(Predicted) |
| | 2H-1-Benzopyran-7-ol, 8-[5-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]-2,2-dimethyl- Usage And Synthesis |
| Uses | Anti-osteoporosis agent-1 (comp 4aa) is a potent replication protein A (RPA) inhibitor (IC50=18 μM) [1]. | | References | [1] Kriti Sharma, et al. Pyrazoline analogues: Design, synthesis, and evaluation of anti-osteoporosis activity. Bioorg Med Chem Lett. 2022 Mar 15; 60:128585. DOI:10.1023/a:1016417624741 |
| | 2H-1-Benzopyran-7-ol, 8-[5-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]-2,2-dimethyl- Preparation Products And Raw materials |
|